Virpax Pharmaceuticals, Inc.
VRPX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40,417 | $80,858 | $24,773 | $123,272 |
| - Cash | $1,513 | $17 | $1,871 | $1,866 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $38,904 | $80,841 | $22,902 | $121,406 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,390 | -$1,903 | -$3,458 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$3,390 | -$2,006 | -$3,450 | -$3,220 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.8 | -0.43 | -1.75 | -2.75 |
| % Growth | -86% | 75.4% | 36.4% | – |
| Operating Cash Flow | -$2,871 | -$4,469 | -$1,644 | -$7,729 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,871 | -$4,469 | -$1,644 | -$7,729 |